Pharvaris | 144:拟议出售证券
04/23 16:23 (美东)
Pharvaris | 144:拟议出售证券
04/15 16:37 (美东)
Pharvaris | F-3ASR:自动仓单登记表
04/12 16:21 (美东)
Pharvaris | 20-F:年度报告/过渡报告/注册声明
04/10 16:18 (美东)
Pharvaris | 6-K:外国发行人报告(业绩相关)
04/10 16:14 (美东)
Pharvaris | 144:拟议出售证券
04/10 12:02 (美东)
Pharvaris | 144:拟议出售证券
03/15 18:16 (美东)
Pharvaris | 144/A:其他
03/15 16:19 (美东)
Pharvaris | 144:拟议出售证券
03/14 18:15 (美东)
Pharvaris | 144:拟议出售证券
03/13 16:31 (美东)
Pharvaris | 144:拟议出售证券
03/11 13:52 (美东)
Pharvaris | F-3ASR:自动仓单登记表
03/06 16:46 (美东)
Pharvaris | 6-K:外国发行人报告
03/06 16:21 (美东)
Pharvaris | 6-K:外国发行人报告
02/16 06:56 (美东)
Pharvaris | 144:拟议出售证券
02/15 08:07 (美东)
Pharvaris | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(6.5%),VHCP Co-Investment Holdings III, LLC(6.5%)等
02/14 20:48 (美东)
Pharvaris | SC 13G/A:超过5%持股股东披露文件(修正)-Viking Global Investors LP(7.0%),Viking Global Opportunities Parent GP LLC(7.0%)等
02/14 10:31 (美东)
Pharvaris | SC 13G/A:超过5%持股股东披露文件(修正)-Foresite Capital Fund IV, L.P. (“FCF IV”)(7.8%),Foresite Capital Management IV, LLC (“FCM IV”)(7.8%)等
02/13 14:20 (美东)
Pharvaris | SC 13G/A:超过5%持股股东披露文件(修正)-General Atlantic, L.P.(14.1%),General Atlantic PH B.V.(14.1%)等
02/13 10:15 (美东)
Pharvaris | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(9.989%),Abigail P. Johnson(9.989%)
02/09 09:35 (美东)
暂无数据
暂无数据